Roberto Piciotti
Impact in
-
- HER2/EGFR in Cancer Research
- Bone health and treatments
-
- Cancer Genomics and Diagnostics
Papers in
- Oncology 7
- Cancer Immunotherapy and Biomarkers 2
-
- Liver Disease Diagnosis and Treatment 4
- Co-authors
- Elham Sajjadi (9 shared papers)Nicola Fusco (9 shared papers)Konstantinos Venetis (8 shared papers)Marco Invernizzi (5 shared papers)Carmen Criscitiello (3 shared papers)Stefania Morganti (2 shared papers)Marica Meroni (5 shared papers)Paola Dongiovanni (5 shared papers)
- Journals
- Frontiers in Oncology (1 paper)Cellular and Molecular Gastroenterology and Hepatology (1 paper)Cancer Cell International (1 paper)Cell Death and Disease (1 paper)International Journal of Molecular Sciences (1 paper)
- Partner nations
- ItalyUnited KingdomBelgium
In The Last Decade
Roberto Piciotti
15 papers receiving 329 citations
Peers
Comparison fields: 5 of 51
- Oncology 116
- Cancer Research 63
- Hepatology 25
- Epidemiology 88
- Pathology and Forensic Medicine 32
Countries citing papers authored by Roberto Piciotti
This map shows the geographic impact of Roberto Piciotti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Piciotti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Piciotti more than expected).
Fields of papers citing papers by Roberto Piciotti
This network shows the impact of papers produced by Roberto Piciotti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Piciotti. The network helps show where Roberto Piciotti may publish in the future.
Co-authors
The 25 scholars most cited alongside Roberto Piciotti, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 87 | |
| 2 | 2021 | 60 | |
| 3 | 2021 | 29 | |
| 4 | 2021 | 26 | |
| 5 | 2021 | 24 | |
| 6 | 2022 | 24 | |
| 7 | 2020 | 20 | |
| 8 | 2021 | 20 | |
| 9 | 2021 | 9 | |
| 10 | 2021 | 9 | |
| 11 | 2021 | 7 | |
| 12 | 2021 | 6 | |
| 13 | 2022 | 5 | |
| 14 | 2022 | 3 | |
| 15 | 2024 | 2 |
About Roberto Piciotti
Roberto Piciotti is a scholar working on Oncology, Epidemiology, Cancer Research, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 15 papers that have together received 331 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (4 papers), Cancer Genomics and Diagnostics (3 papers), Breast Cancer Treatment Studies (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Muscle Physiology and Disorders (2 papers), Lung Cancer Treatments and Mutations (2 papers), Genetic factors in colorectal cancer (2 papers) and Diabetes and associated disorders (1 paper). The work is most often cited by research in Oncology (116 citations), Cancer Research (63 citations), Hepatology (25 citations), Epidemiology (88 citations) and Pathology and Forensic Medicine (32 citations). Roberto Piciotti has collaborated with scholars based in Italy, United Kingdom and Belgium. Frequent co-authors include Elham Sajjadi, Nicola Fusco, Konstantinos Venetis, Marco Invernizzi, Carmen Criscitiello, Stefania Morganti, Marica Meroni, Paola Dongiovanni, Elena Guerini‐Rocco and Anna Ludovica Fracanzani. Their work appears in journals such as Frontiers in Oncology, Cellular and Molecular Gastroenterology and Hepatology, Cancer Cell International, Cell Death and Disease and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.